Covid-19 associated coagulopathy (CAC): Global research output, 2020-2022

Authors

  • B.M. Gupta Formerly with CSIR-NISTADS, New Delhi 110012, India.
  • Mallikarjun M. Kappi Government First Grade College, Jagalur – 577528, Karnataka, India
  • Rajpal Walke CSIR-NPL, New Delhi 110 012, India
  • Madhu Bansal Panjab University image/svg+xml
  • Aurum Mandal N-042, DLF Capital Greens, Karampura, Moti Nagar, Delhi-110015

DOI:

https://doi.org/10.47909/ijsmc.48

Keywords:

Covid-19, coagulopathy, research trends, bibliometrics

Abstract

Objective. This study examined the Covid-19 associated coagulopathy (CAC) publication and citation trends, focusing on the top authors, countries, organizations, journals, collaboration, subject areas, keywords, and high-cited articles.

Design/Methodology/Approach. Publications data on Covid-19 associated coagulopathy (CAC) were identified and extracted from the Scopus database. Data analysis has been performed using VOS viewer software, Biblioshiny, and MS Excel Software.

Results/Discussion. The study identified 1740 articles on Covid-19 associated coagulopathy from the Scopus database, which received 47,502 citations, averaging 27.3 citations per paper. In all, 905 authors from 601 organizations originating in 96 countries participated in research and published in 776 journals. United States, Italy, and China contributed the most publications (498, 258, and 164 papers). While China (73.43 and 2.69), France (57.60 and 2.11,) and Germany (50.13 and 1.84) registered the highest citation impact by CPP and RCI. Harvard Medical School, USA, Huazhong University of S&T, China, and Tongji Medical College, China, lead with most of the publications (4,4, 41, and 39 papers). In contrast, Tongji Medical College, China (198.31 and 7.26), Huazhong University of S&T, China (198.15 and 7.26), and University College Hospital NHS Foundation Trust, U.K (129.23 and 4.73) lead in citation impact. J.H. Levy, T. Iba and M. Levy contributed to most of the publications (27, 25, and 20), while N. Tag (804.75 and 29.48), A. Tripodi (157.83 and 5.78), and J. Thachil (154.17 and 5.65) registered the highest citation impact by CPP and RCI. Journal of Thrombosis and Haemostasis, Journal of Thrombosis and Thrombolysis, and Thrombosis Research were the most productive ones (with 55, 51, and 46 publications). At the same time, Medical Hypotheses (1222), Blood (355.71) and Thrombosis Journal (233.86) were the most impactful journals. The top 9 keywords were Covid-19 (1681 occurrences), Blood Clotting (952), D Dimer (652), C (628), Coagulopathy (628), Thrombosis (584), blood (506), Anticoagulants (499), Blood Coagulation (426) and Fibrinogen (376).

Conclusions. Global research on Covid-19 associated coagulopathy since the pandemic was considered for scientometric assessment for the first time, combining the productivity and citation measures to present an overall picture of the literature in this area. Such an analysis will provide scholars and policy-makers with a meaningful reference for further exploration of topical issues and research trends in the field.

Downloads

Download data is not yet available.

References

Bell, R., Zini, G., d’Onofrio, G., Rogers, H. J., Lee, Y. S., & Frater, J. L. (2021). The hematology laboratory’s response to the COVID‐19 pandemic: A scoping review. International Journal of Laboratory Hematology, 43(2), 148-159. DOI: 10.1111/ijlh.13381

Bell, R., Zini, G., d’Onofrio, G., Rogers, H. J., Lee, Y. S., & Frater, J. L. (2021). The hematology laboratory’s response to the COVID‐19 pandemic: A scoping review. International Journal of Laboratory Hematology, 43(2), 148-159. DOI: 10.1111/ijlh.13381 DOI: https://doi.org/10.1111/ijlh.13381

Connors, J. M., & Levy, J. H. (2020). COVID-19 and its implications for thrombosis and anticoagulation. Blood, 135(23), 2033-2040. https://doi.org/10.1182/blood.2020006000 DOI: https://doi.org/10.1182/blood.2020006000

Conway, E. M., Mackman, N., Warren, R. Q., Wolberg, A. S., Mosnier, L. O., Campbell, R. A., ... & Morrissey, J. H. (2022). Understanding COVID-19-associated coagulopathy. Nature Reviews Immunology, 22(10), 639-649. DOI: 10.1038/s41577-022-00762-9. DOI: https://doi.org/10.1038/s41577-022-00762-9

Durğun, M., Uyar, C., Demiray, E. K. D., Tahmaz, A., & Tokur, M. E. (2021). Analysis of publications on pulmonary embolism in the COVID-19 era. Radiology, 270(25), 3. DOI: 10.5606/fng.btd.2021.25061

Durğun, Mehmet et al. (2021). Analysis of publications on pulmonary embolism in the Covid-19 era. D J Med Sci, 7(2), 141-146. DOI: 10.5606/fng.btd.2021.25061.

Gupta, B. M., Ahmed, K. M., Bansal, M., & Mamdapur, G. M. (2021 B). Thrombosis research in India: A bibliometric assessment of publications output during 2000-19. International Journal of Medicine & Public Health, 11(1), 10-18. https://dx.doi.org/10.5530/ijmedph.2021.2.14

Gupta, B. M., Dhawan, S. M., Ahmed, K. M., & Mamdapur, G. M. (2021 A). Global research on Covid-19 disease: A scientific assessment of publications during 2020-21. International Journal of Medicine & Public Health, 11(2), 76-84. https://dx.doi.org/10.5530/ijmedph.2021.2.14 DOI: https://doi.org/10.5530/ijmedph.2021.2.14

Guven, Z. T. (2022). Covid-19 Related Hematology and Oncology Publications. Med Bull Haseki, 60, 92-98. DOI: 10.4274/haseki.galenos.2022.7965. DOI: https://doi.org/10.4274/haseki.galenos.2022.7965

Lauretani, F., Ravazzoni, G., Roberti, M. F., Longobucco, Y., Adorni, E., Grossi, M., ... & Maggio, M. (2020). Assessment and treatment of older individuals with COVID-19 multi-system disease: clinical and ethical implications. Acta Bio Medica: Atenei Parmensis, 91(2), 150. https://doi.org/10.23750%2Fabm.v91i2.9629

Lippi, G., Sanchis-Gomar, F., Favaloro, E. J., Lavie, C. J., & Henry, B. M. (2021, January). Coronavirus disease 2019–associated coagulopathy. In Mayo Clinic Proceedings (Vol. 96, No. 1, pp. 203-217). Elsevier. https://doi.org/10.1016/j.mayocp.2020.10.031 DOI: https://doi.org/10.1016/j.mayocp.2020.10.031

Mahase, E. (2020). Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. Bmj, 368(March), m1036. https://doi.org/10.1136/bmj.m1036 DOI: https://doi.org/10.1136/bmj.m1036

Mian, M. K., Sreedharan, S., Limaye, N. S., Hogan, C., & Darvall, J. N. (2020, November). Research trends in anticoagulation therapy over the last 25 years. In Seminars in thrombosis and hemostasis (Vol. 46, No. 08, pp. 919-931). Thieme Medical Publishers, Inc. DOI: 10.1055/s-0040-1718892 DOI: https://doi.org/10.1055/s-0040-1718892

Özyalçın, S; & Erol, M. E. (2021). Bibliometric analysis on deep vein thrombosis. KÜ Tıp Fak Derg, 23(3), 569-584. DOI: 10.24938/kutfd.976436. DOI: https://doi.org/10.24938/kutfd.976436

Solanki, Y. (2021). What is coagulopathy? https://study.com/academy/lesson/coagulopathies-types-causes-treatment.html

Sun, Y., Li, X., Zhang, Y., Tang, S. (2022). The research status of central venous catheterization-associated thrombosis: a bibliometrics analysis. Annals of Translational Medicine, 10(10), https://atm.amegroups.com/article/view/94682 DOI: https://doi.org/10.21037/atm-22-1552

Downloads

Published

2023-06-02

How to Cite

Gupta, B., Kappi, M. M., Walke, R., Bansal, M., & Mandal, A. (2023). Covid-19 associated coagulopathy (CAC): Global research output, 2020-2022 . Iberoamerican Journal of Science Measurement and Communication, 3(2). https://doi.org/10.47909/ijsmc.48